Cannabinoids Enhance Subsecond Dopamine Release in the Nucleus Accumbens of Awake Rats

Journal of Neuroscience

Volumn 24, Issue 18, 2004, Pages 4393-4400

  Cheer, Joseph F ^a,c   Wassum, Kate M ^b   Heien, Michael L A V ^a,c   Phillips, Paul E M ^a,b,c   Wightman, R Mark ^a,c  

^a The University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Accumbens; Cannabinoids; Cyclic voltammetry; Dopamine; Drug abuse; Neuromodulation

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CANNABIS; DOPAMINE; N PIPERIDINO 5 (4 CHLOROPHENYL) 1 (2,4 DICHLOROPHENYL) 4 METHYLPYRAZOLE 3 CARBOXAMIDE; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANNABIS ADDICTION; CATALEPSY; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC NEUROTRANSMISSION; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG ABUSE; DRUG ANTAGONISM; ELECTROSTIMULATION; EXTRACELLULAR SPACE; FAST SCAN CYCLIC VOLTAMMETRY; LIMBIC SYSTEM; LOCOMOTION; MALE; MESOCORTICOLIMBIC SYSTEM; NERVE PROJECTION; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REINFORCEMENT; STRIATE CORTEX; VENTRAL TEGMENTUM; WAKEFULNESS;

ANIMALS; CANNABINOIDS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ELECTROCHEMISTRY; ELECTRODES, IMPLANTED; MALE; MEDIAL FOREBRAIN BUNDLE; MORPHOLINES; MOTOR ACTIVITY; NAPHTHALENES; NUCLEUS ACCUMBENS; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; SYNAPTIC TRANSMISSION; TIME FACTORS; WAKEFULNESS;

EID: 2342668029     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0529-04.2004     Document Type: Article

References (49)

1. Budygin EA, Phillips PEM, Robinson DL, Kennedy AP, Gainetdinov RR, Wightman RM (2001) Effect of acute ethanol on striatal dopamine neurotransmission in ambulatory rats. J Pharmacol Exp Ther 297:27-34.
2. Chen JP, Paredes W, Lowinson JH, Gardner EL (1991) Strain-specific facilitation of dopamine efflux by delta 9-tetrahydrocannabinol in the nucleus accumbens of rat: an in vivo microdialysis study. Neurosci Lett 129:136-180.
3. Cheer JF, Marsden CA, Kendall DA, Mason R (2000a) Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study. Neuroscience 99:661-667.
4. Cheer JF, Kendall DA, Marsden CA (2000b) Cannabinoid receptors and reward in the rat: a conditioned place preference study. Psychopharmacology (Berl) 151:25-30.
5. Cheer JF, Kendall DA, Mason R, Marsden CA (2003) Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum. Neuropharmacology 44:633-641.
6. Diana M, Melis M, Gessa GL (1998) Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids. Eur J Neurosci 10:2825-2830.
7. Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278.
8. Fattore L, Martellotta MC, Cossu G, Mascia MS, Fratta W (1999) CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats. Behav Brain Res 104:141-146.
9. French ED (1997) delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neurosci Lett 226:159-162.
10. French ED, Dillon K, Wu X (1997) Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. NeuroReport 8:649-652.
11. Freund TF, Katona I, Piomelli D (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83:1017-1066.
12. Gardner EL (2002) Addictive potential of cannabinoids: the underlying neurobiology. Chem Phys Lipids 121:267-290.
13. Garris PA, Christensen JRC, Rebec GV, Wightman RM (1997) Real-time measurement of electrically evoked extracellular dopamine in the striatum of freely moving rats. J Neurochem 68:152-161.
14. Garris PA, Kilpatrick M, Bunin MA, Michael D, Walker QD, Wightman RM (1999) Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation. Nature 398:67-69.
15. Gessa GL, Muntoni F, Collu M, Vargiu L, Mereu G (1985) Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res 348:201-203.
16. Gessa GL, Melis M, Muntoni AL, Diana M (1998) Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur J Pharmacol 341:39-44.
17. Gonon FG (1988) Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 24:19-28.
18. Gonon FG, Buda MJ (1985) Regulation of dopamine release by impulse flow and by autoreceptors as studied by in vivo voltammetry in the rat striatum. Neuroscience 14:765-774.
19. Heien MLAV, Phillips PEM, Stuber GD, Seipel AT, Wightman RM (2003) Overoxidation of carbon-fiber microelectrodes enhances dopamine adsorption and increases sensitivity. Analyst 128:1413-1419.
20. Hernàndez M, Berrendero F, Suàrez I, García-Gil L, Cebeira M, Mackie K, Ramos JA, Fernàndez-Ruiz J (2000) Cannabinoid CB1 receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme. Brain Res 857:57-65.
21. Hyland BI, Reynolds JNI, Hay J, Perk CG, Miller R (2002) Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience 114:475-492.
22. Ikemoto S, Panksepp J (1999) The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Brain Res Rev 31:6-41.
23. Mechoulam R, Gaoni Y (1967) The absolute configuration of delta-9-tetrahydrocannabinol, the major active constituent of hashish. Tetrahedron Lett 12:1109-1111.
24. Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL (2004) Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci 24:53-62.
25. Michael DJ, Joseph JD, Kilpatrick MR, Travis ER, Wightman RM (1999) Improving data acquisition for fast-scan cyclic voltammetry. Anal Chem 71:3941-3947.
26. Montague PF, McClure SM, Baldwin PR, Phillips PEM, Budygin EA, Stuber GD, Kilpatrick MR, Wightman RM (2004) Dynamic gain control of dopamine delivery in freely moving animals. J Neurosci 24:1754-1759.
27. Nestler EJ (2002) From neurobiology to treatment: progress against addiction. Nat Neurosci 5:1076-1079.
28. Overton PG, Clark D (1997) Burst firing in midbrain dopaminergic neurons. Brain Res Brain Res Rev 3:312-334.
29. Phillips PEM, Wightinan RM (2003) Critical guidelines for validation of the selectivity of in-vivo chemical microsensors. Trends Anal Chem 22:509-514.
30. Phillips PEM, Stuber GD, Heian MLAV, Wightman RM, Carelli RM (2003) Subsecond dopamine relesse promotes cocaine seeking. Nature 22:614-618.
31. Robinson DL, Heien MLAV, Wightman RM (2002) Frequency of dopamine concentration transients increases in dorsal and ventral striatum of male rats during introduction of conspecifics. J Neurosci 2:10477-10486.
32. Roitman MF, Stuber GD, Phillips PEM, Wightman RM, Carelli RM (2004) Dopamine operates as a subsecond modulator of food seeking. J Neurosci 24:1265-1271.
33. Rosebush PI, Mazurek MF (1995) Complicating factors in the analysis of acute drug-induced akathisia. Arch Gen Psychiatry 52:878-880.
34. Sañudo-Peña MC, Tsou K, Delay ER, Hohman AG, Force M, Walker JM (1997) Endogenous cannabinoids as an aversive or counter-rewarding system in the rat. Neurosci Lett 223:125-128.
35. Sañudo-Peña MG, Romero J, Seale GE, Fernandez-Ruiz JJ, Walker JM (2000) Activational role of cannabinoids on movement. Eur J Pharmacol 391:269-274.
36. Schlicker E, Kathmann M (2001) Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 22:565-572.
37. Schultz W (1998) Predictive reward signal of dopamine neurons. J Neurophysiol 1:1-27.
38. Szabo B, Muller T, Koch H (1999) Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro. J Neurochem 73:1084-1089.
39. Szabo B, Siemes S, Wallmichrath I (2002) Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Eur J Neurosci 15:2057-2061.
40. Tanda G, Pontieri FE, Di Chiara G (1997) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276:2048-2050.
41. Tanda G, Loddo P, Di Chiara G (1999) Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol. Eur J Pharmacol 376:23-26.
42. Tanda G, Goldberg SR (2003) Cannabinoids: reward, dependence, and underlying neurochemical mechanisms - a review of recent preclinical data. Psychopharmacology (Berl) 169:115-134.
43. Venton BJ, Michael DJ, Wightman RM (2003a) Correlation of local changes in extracellular oxygen and pH that accompany dopaminergic terminal activity in the rat caudate-putamen. J Neurochem 84:373-381.
44. Venton BJ, Zhang H, Garris PA, Phillips PEM, Sulzer D, Wightman RM (2003b) Real-time decoding of dopamine concentration changes in the caudateputamen during tonic and phasic firing. J Neurochem 87:1284-1295.
45. Wightman RM, Amatore C, Engstrom RC, Hale PD, Kristensen EW, Kuhr WG, May LJ (1988) Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience 25:513-523.
46. Wiley JL, Martin BR (2003) Cannabinoid pharmacological properties common to other centrally acting drugs. Eur J Pharmacol 471:185-193.
47. Wilson PI, Nicoll RA (2002) Endocannabinoid signaling in the brain. Science 296:678-682.
48. Wise RA (2002) Brain reward circuitry: insights from unsensed incentives. Neuron 36:229-240.
49. Wu X, French ED (2000) Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment. Neuropharmacology 39:391-398.